Elokom, 0.1%, cream for external use, 15 g, 1 pc.

Composition and release form

Elokom®

in tubes of 15 g; 1 tube in a cardboard box.

in tubes of 15 g; 1 tube in a cardboard box.

in bottles of 20 ml; 1 bottle in a cardboard box.

Elocom® Lotion

PE dropper bottles of 20 ml; 1 bottle in a cardboard box.

Elokom price, where to buy

The average price of Elokom cream is 370 rubles.

The price of Elokom ointment varies between 360-380 rubles.

The price of Elokom lotion is about 200 rubles.

• Online pharmacies in RussiaRussia
• Online pharmacies in UkraineUkraine
• Online pharmacies in KazakhstanKazakhstan

LuxPharma* special offer

• Elokom ointment 0.1% tube 30g
  RUB 1,550 order
• Elokom cream 0.1% tube 30g

  RUB 1,570 order

show more

Pharmacy24

• Elokom 15 g ointment Schering-Plough Labo N.V., Belgium
  154 UAH order
• Elokom 30 ml lotion Famar Montreal Inc., Canada

  267 UAH order

PaniPharmacy

• Elokom S ointment Elokom S ointment 15g Portugal, Schering-Plough Pharma

  186 UAH order

• Elokom cream Elokom cream 0.1% 15g Belgium, Schering-Plough Labo

  187 UAH order

• Elokom cream Elokom cream 0.1% 30g Belgium, Schering-Plough Labo

  232 UAH. order

• Elokom liquid Elokom lotion 0.1% 30ml Spain, Schering-Plough

  333 UAH. order

• Elokom ointment Elokom ointment 0.1% 30g Belgium, Schering-Plough Labo

  207 UAH. order

show more

pharmachologic effect

Pharmacological action - antiexudative, antipruritic, anti-inflammatory.

The mechanism of action appears to involve inducing the release of proteins that inhibit phospholipase A2 and are collectively known as lipocortins. These proteins are thought to control the biosynthesis of potent inflammatory mediators such as PG and LT by inhibiting the release of their common precursor, arachidonic acid.

Carcinogenesis, mutagenesis. Genetic toxicity studies of mometasone furoate, including the Ames test, the murine lymphoma test, and the micronucleus test, showed no evidence of mutagenicity.

Long-term animal experiments aimed at assessing the carcinogenic effect of the drug have not been conducted.

Pharmacokinetics

The extent to which topical glucocorticosteroids penetrate the skin depends on many factors, including the composition of the drug and the integrity of the epidermal barrier. Inflammation and other processes occurring in the skin can lead to increased penetration of the drug through the skin. With a single local application to intact skin (without an occlusive dressing), approximately 0.7% of the ointment dose and approximately 0.4% of the cream are detected in the blood after 8 hours. There is reason to believe that the level of absorption of the glucocorticosteroid in the dosage form of the lotion is also insignificant.

Analogs

Level 4 ATC code matches:
Gistan-N

Sinalar

Avecourt

Mesoderm

Momederm

Betazon

Silkaren

Flucinar

Sinaflan

Celestoderm

Cutivate

Advantan

Betamethasone

Beloderm

Mometasone Furoate

Uniderm

Momat

The main analogues of Elokom ointment: Uniderm and Mometasone . These drugs are also analogues of the cream. If you need to choose cheaper analogues, then it is better to consult your doctor.

Use during pregnancy and breastfeeding

There have been no adequate, well-controlled studies of the teratogenic potential of mometasone furoate when used during pregnancy. The use of Elokom cream, ointment or lotion during pregnancy is possible only if the expected benefits of treatment for the mother outweigh the potential risk to the fetus.

When used systemically, glucocorticosteroids appear in breast milk, which can lead to slower growth of the child, an impact on the endogenous synthesis of glucocorticosteroids and other adverse effects. There is no evidence that systemic absorption of glucocorticosteroids when applied topically can lead to the appearance of detectable amounts in breast milk. However, due to the fact that many drugs are excreted in breast milk, nursing women should use Elokom cream, ointment, and lotion with caution.

Contraindications

The medicine should not be used to get rid of diaper dermatitis and other skin irritations in infants. Other contraindications include:

• allergic reactions to the components of the drug;
• open injuries: bleeding scratches, abrasions, wounds;
• neoplasms at the sites of application of the product: moles, papillomas;
• diagnosed insufficiency of the adrenal glands, hypothalamus and pituitary gland.

Elokom should not be applied to sensitive skin of the face, groin area, or axillary areas.

The drug is prescribed to pregnant women with caution in emergency cases: with intense acute symptoms of dermatoses, when the benefit to the mother outweighs the likely risk to the health of the fetus. There is insufficient information about the effect of Elokom on intrauterine development, but no cases of teratogenic effect have been recorded.

Side effects

Cream. In controlled clinical studies on 319 patients, the incidence of adverse events associated with the use of Elokom cream was 1.6%. Burning, itching, skin atrophy were noted; There have been reports of rosacea. In controlled clinical studies in children aged 2 to 12 years (n=74), the incidence of adverse events (burning, itching, furunculosis) associated with the use of the cream was approximately 7%.

Ointment. In controlled clinical studies on 812 patients, the incidence of adverse events associated with the use of Elokom ointment was 4.8%. Burning, tingling, itching, skin atrophy, furunculosis were noted; There have been reports of rosacea. In controlled clinical studies in children aged 2 to 12 years (n=74), the incidence of adverse events (burning, itching, furunculosis) associated with the use of the ointment was approximately 7%.

Lotion. In clinical studies on 209 patients, the following adverse events were noted: burning (4 cases), acne (2 cases), itching (1 case). In a hypersensitivity study of 156 healthy volunteers, folliculitis occurred (4 cases).

With topical use of glucocorticosteroid drugs, the following adverse events may rarely occur in descending order of frequency: skin irritation and dryness, folliculitis, hypertrichosis, acne, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin maceration, secondary infection, stretch marks and miliaria. The likelihood of these adverse events occurring increases with the use of occlusive dressings.

Directions for use and doses

Locally.

Elokom®

Apply a thin layer of cream or ointment to the affected areas of the skin once a day.

Lotion - apply a few drops to the affected areas of the skin once a day; After application, the lotion is rubbed in with gentle movements until it disappears from the surface of the skin. For the most effective and economical use of the drug, it is necessary to bring the spout of the bottle closer to the affected area of ​​​​the skin and lightly squeeze the bottle.

Elocom® Lotion

Lotion - apply a few drops to the affected areas of the skin once a day; After application, the lotion is rubbed in with gentle movements until it disappears from the surface of the skin. For the most effective and economical use of the drug, it is necessary to bring the spout of the bottle closer to the affected area of ​​​​the skin and lightly squeeze the bottle.

The duration of treatment is determined by its effectiveness, as well as patient tolerability, the presence and severity of side effects.

Precautionary measures

Elokom cream, ointment, lotion are indicated only for dermatological use and are not intended for use in ophthalmology.

As a result of systemic absorption with local use of various glucocorticosteroid drugs, reversible suppression of the function of the hypothalamic-pituitary-adrenal system, as well as symptoms of glucocorticosteroid insufficiency after discontinuation of the drug, may occur. In patients, as a result of systemic absorption of glucocorticosteroids during systemic use, Cushing's syndrome, hyperglycemia and glycosuria may also develop.

Patients receiving topical corticosteroids for the treatment of large areas of skin or under occlusive dressings should be periodically monitored for signs of suppression of the hypothalamic-pituitary-adrenal axis. This can be done by performing an ACTH stimulation test, measuring morning cortisol in plasma and in media other than urine. If suppression of the hypothalamic-pituitary-adrenal system is noted, the interval between applications should be increased, or another less potent glucocorticosteroid should be used, or the drug should be discontinued. Restoration of the function of the hypothalamic-pituitary-adrenal system usually occurs soon after discontinuation of local glucocorticosteroids. Sometimes signs and symptoms of glucocorticosteroid deficiency may appear, which requires additional use of systemic glucocorticosteroids, a description of which can be found in the annotations for such drugs.

The drug Elokom can be used in children from 2 years of age, however, it should be borne in mind that the safety and effectiveness of its use in children for a period exceeding 3 weeks have not been studied.

Due to the fact that children have a larger surface area to body weight ratio than adults, children are at greater risk of suppressing the function of the hypothalamic-pituitary-adrenal axis and the occurrence of Cushing's syndrome when using any topical glucocorticosteroid drugs. For the same reason, children have a higher risk of adrenal insufficiency when treatment with topical glucocorticosteroids is discontinued. When treated with local glucocorticosteroids in children, atrophic changes in the skin occur more easily, up to the appearance of atrophic stripes. The risk of suppression of the hypothalamic-pituitary-adrenal system in children increases when glucocorticosteroids are applied to an area of ​​more than 20% of the body surface.

There are reports of suppression of the function of the hypothalamic-pituitary-adrenal system, the appearance of Cushing's syndrome, growth retardation, delayed weight gain and intracranial hypertension in children with topical use of various glucocorticosteroid drugs. Manifestations of adrenal insufficiency include low plasma cortisol and lack of response to ACTH stimulation. Intracranial hypertension leads to bulging fontanelles, headache, and bilateral papilledema.

Elokom ointment and cream should not be used to treat dermatitis caused by wearing diapers.

Ointment, cream and lotion should not be used under occlusive dressings unless prescribed by a doctor. Ointment and cream should not be applied to children on areas of skin that are under diapers or under waterproof underpants (occlusive dressing effect). The ointment and cream are not intended for use on the face or in the groin and armpit areas.

If irritation occurs, use of Elokom should be discontinued and appropriate treatment prescribed. Allergic contact dermatitis with corticosteroids is usually diagnosed by evidence of treatment failure, which should be confirmed by skin testing.

If a concomitant skin infection develops, an appropriate antifungal or antibacterial agent should be used. If a positive response to treatment is not achieved quickly, use of the drug should be suspended until the infection is eliminated.

As with other glucocorticosteroids, use of Elokom cream, ointment and lotion should be discontinued once cured. If there is no improvement within 2 weeks after starting therapy, the diagnosis may need to be clarified.

Reviews about Elokom

Among the numerous discussions about the treatment of various skin diseases, reviews of Elokom ointment are found quite often. At the same time, many patients note its high effectiveness. It is also actively discussed whether it is possible to apply the ointment to children and in what specific cases this should be done. It is important to remember that this drug can only be used for children over 2 years of age.

There are often reviews of Elokom cream, although in this case users are not so much interested in the effectiveness of the drug as in the question: is the cream hormonal or not, just like Elokom ointment - is it hormonal or not? Although it is the cream that patients use more often than others.

Of course, many patients use this remedy when various skin rashes appear without specifying the diagnosis and, especially, without a doctor’s prescription, although it is a specialist who will help decide which is better - ointment or cream. Reviews of the lotion show that in most cases it helps well in the initial stage of treatment. However, long-term use can cause increased symptoms. This may be both a manifestation of side effects and an indication that the drug is being used for other purposes. Among other things, users are interested in how to use Elokom lotion for hair, which, however, the instructions for the product do not recommend.

A separate topic is the use of the drug for children. Interestingly, reviews of Elokom for infants show that some parents are trying to treat dermatitis caused by wearing diapers. As you know, this is contraindicated, especially since it can only be used for children over 2 years old.

Thus, the effectiveness of this drug cannot be in doubt. But it should be used only as prescribed by a specialist, after an accurate diagnosis.